Acute kidney injury in a child treated with cisplatin and amphotericin B. [PDF]
Skajaa T, Faerch M, Hasle H.
europepmc +1 more source
Efficacy and Safety of Amphotericin B Colloidal Dispersion for Patients with Invasive Fungal Disease and Febrile Neutropenia: A Registry-Based, Multicenter, Retrospective, Real-World Study. [PDF]
Zhang L+8 more
europepmc +1 more source
Gladiolin produced by pathogenic Burkholderia synergizes with amphotericin B through membrane lipid rearrangements. [PDF]
Simm C+13 more
europepmc +1 more source
Amphotericin B in the Era of New Antifungals: Where Will It Stand? [PDF]
Akinosoglou K+7 more
europepmc +1 more source
Understanding the synergistic interaction between a 1,3,4-thiadiazole derivative and amphotericin B using spectroscopic and theoretical studies. [PDF]
Ślusarczyk L+11 more
europepmc +1 more source
Insight into Virulence and Mechanisms of Amphotericin B Resistance in the Candida haemulonii Complex. [PDF]
Huang Y, Su Y, Chen X, Xiao M, Xu Y.
europepmc +1 more source
ERRATUM: Prevention of amphotericin B nephrotoxicity through use of phytotherapeutic medication. [PDF]
europepmc +1 more source
Paving the way for affordable and equitable liposomal amphotericin B access worldwide.
Lee JSF+18 more
europepmc +1 more source
Related searches:
Invasive fungal infections are a major cause of morbidity and mortality in immunodeficient individuals (such as AIDS patients) and in transplant recipients or tumor patients undergoing immunosuppressive chemotherapy. Amphotericin B is one of the oldest, yet most efficient antimycotic agents. However, its usefulness is limited due to dose-dependent side-
Lemke, A.+2 more
openaire +3 more sources